Skip to main content
ALVO
NASDAQ Life Sciences

Entity Closely Tied to CEO/Chairman Acquires Over $11.5M in Alvotech Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$4.56
Mkt Cap
$1.361B
52W Low
$4.32
52W High
$13.7
52W Position info
5.6% above low
Off High info
67% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

ALVO is trading near its 52-week low of $4.32 (5.6% above the low).

Summary

An entity closely associated with Alvotech's CEO and Chairman reported a net acquisition of over $11.5 million in company shares, signaling strong insider confidence.


Key Events · Ownership and Investor Activity · ALVO

  • Significant Insider Net Purchase

    ATP Holdings ehf., an entity closely associated with CEO and Chairman Róbert Wessman, reported a net acquisition of 2,701,617 Alvotech shares.

  • Substantial Investment Value

    The net purchase is valued at approximately $11.55 million (SEK 119 million), reflecting a considerable investment by a key insider.

  • Correction of Prior Announcement

    This 6-K filing corrects an earlier announcement, clarifying that the December 19, 2025 transaction was a sale, not an acquisition, resulting in a net acquisition over the two reported dates.


Analysis · ALVO · Life Sciences

ATP Holdings ehf., an entity closely associated with Alvotech's CEO and Chairman Róbert Wessman, reported a net acquisition of shares valued at approximately $11.55 million. This significant insider buying activity, representing a notable portion of the company's market capitalization, signals strong conviction from a key stakeholder. Such a substantial investment by an entity with direct ties to the top leadership can be interpreted by investors as a positive indicator of future prospects and management's belief in the company's valuation.

At the time of this filing, ALVO was trading at $4.56 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $4.32 to $13.70. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ALVO - Latest Insights

ALVO
Jul 01, 2026, 8:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $3.80
Real-time Price: $3.18 info
Change: -$0.620 (-16%) info
Market Cap: $1.21B info
ALVO
Jul 01, 2026, 4:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.73
Real-time Price: $3.18 info
Change: -$0.550 (-15%) info
Market Cap: $1.21B info
ALVO
Jun 30, 2026, 8:08 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $3.69
Real-time Price: $3.18 info
Change: -$0.510 (-14%) info
Market Cap: $1.21B info
ALVO
Jun 18, 2026, 12:32 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $3.88
Real-time Price: $3.18 info
Change: -$0.695 (-18%) info
Market Cap: $1.21B info
ALVO
Jun 18, 2026, 4:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.80
Real-time Price: $3.18 info
Change: -$0.620 (-16%) info
Market Cap: $1.21B info